发明名称 |
HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFOR |
摘要 |
The present invention relates to dosing regimens with half-life extended Factor VIIa (FVIIa) for prophylactic and “on-demand” treatment of bleeding, as well as for preventing a bleeding episode during or after surgery in patients with congenital or acquired bleeding disorders. The present invention further relates to the use of half-life extended FVIIa for treating or preventing blood loss in patients without bleeding disorders in situations of hemorrhage, i.e., due to trauma or surgery. Another aspect of the invention is the treatment of acquired haemophilia. |
申请公布号 |
EP3129408(A1) |
申请公布日期 |
2017.02.15 |
申请号 |
EP20150775929 |
申请日期 |
2015.03.30 |
申请人 |
CSL Limited |
发明人 |
BENSEN-KENNEDY, Debra;VELDMAN, Alex;ZOLLNER, Sabine;HERZOG, Eva |
分类号 |
C07K19/00;A61K38/36;A61P7/04;C07K14/745 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|